“Speaking truth to power”
- a Quaker maxim.
 
Top News arrow News / Infomails
News and Infomails from AHRP
Company Knew of the Catastrophic Risk--so did the British Medicines Authority Print E-mail
Sunday, 09 April 2006
"Risks of anaphylaxis applies to all studies at PAREXEL, with drugs at every stage of development, and the staff are well trained in anticipation of this (unlikely) possibility.
Read more...
 
British Rethinking Rules After Ill-Fated Drug Trial_NYT Print E-mail
Saturday, 08 April 2006
A front page report in The New York Times provides additonal information about the catastrophic TGN1412 medical experiment in which 6 previously healthy volunteers were intravenously injected with monoclonal antibody in a highly risky procedure.
Read more...
 
London Drug Trial Catastrophe: Collapse of Science and Ethics Print E-mail
Friday, 07 April 2006
The independent Institute of Science in Society (ISIS) challenges the report issued by the UK government medicines oversight agency, MHRA (equivalent to US FDA), absolving itself and those involved from any responsibility for a catastrophic human experiment that nearly killed six healthy volunteers.
Read more...
 
Red Light Districts in State Capitols_Peter Rost Print E-mail
Thursday, 06 April 2006
The Pharmaceutical industry rakes in $500 billion globally--$230 billion in North America--57% of revenues is on marketing.
Read more...
 
More...
<< Start < Prev 41 42 43 44 45 46 47 48 49 50 Next > End >>

Results 575 - 588 of 753
[ Back ]
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]